Cardiology
News
Dapagliflozin misses as treatment for COVID-19 but leaves intriguing signal for benefit
The SGLT2 inhibitor dapagliflozin was not associated with significant benefit in COVID-19 patients but came close.
News
PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MI
SHM Converge
Update in Hospital Medicine relays important findings
Two panelists highlighted the year of research in areas most relevant and important to hospital medicine.
News
Reassuring data on impact of mild COVID-19 on the heart
News
Infective endocarditis with stroke after TAVR has ‘dismal’ prognosis
News
Nutritional support may be lifesaving in heart failure
Patients with high-risk chronic heart failure given individualized nutritional support in-hospital had lower mortality following discharge, a new...
News
Hypertension worsened by commonly used prescription meds
Close to 20% of U.S. adults with hypertension are on a prescription drug, such as NSAIDs, known to raise blood pressure, creating an opportunity...
SHM Converge
Torsemide over furosemide as first-line loop diuretic for HF
One “Thing We Do for No Reason” is use furosemide rather than torsemide as loop diuretic for patients with heart failure, said Dr. Anthony Breu....
Clinical
Torsemide vs. furosemide in heart failure patients
Does the use of torsemide improve clinical outcomes when compared with furosemide?
News
Higher MI shock survival with NCSI protocol: Final results
Final results of the National Cardiogenic Shock Initiative show better survival rates in acute MI shock than seen in previous North American...